Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.

Ruiying WangLorena V N OliveiraMaureen M HesterDiana CarlsonDennis ChristensenCharles A SpechtStuart M Levitz

Published in: bioRxiv : the preprint server for biology (2024)

T cell responses were also observed, albeit in lesser numbers. Our promising findings from this preclinical research paves the way for future human cryptococcal vaccine trials.

Keyphrases

endothelial cells
early stage
drug delivery
induced pluripotent stem cells
current status
pluripotent stem cells
cell therapy
protein kinase